Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions

Journal of Cutaneous Pathology

Volumn 23, Issue 3, 1996, Pages 234-241

  Prieto, Victor G ^a   Lugo, Jorge ^a   McNutt, N Scott ^b  

^a Department of Obstetrics Gynecology   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; FORMALDEHYDE; KERATIN; MONOCLONAL ANTIBODY; PARAFFIN;

ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; CONTROLLED STUDY; EPIDERMIS; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MERKEL CELL TUMOR; MOLECULAR WEIGHT; PROTEIN EXPRESSION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MELANOMA; MOLECULAR WEIGHT; PARAFFIN EMBEDDING; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0029941316     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01472.x     Document Type: Article

References (29)

1. Prieto VG, McNutt NS, Lugo J. Cytokeratin identification in 148 skin tumors as detected by the monoclonal antibody MNF116 (abstract). Lab Invest 1993: 68: 36A.
2. Leong A S-Y, Wright J. The contribution of immunohistochemical staining in tumor diagnosis. Histopathology 1987: 11: 1295.
3. Corwin DJ, Gown AM. Review of selected lineage-directed antibodies useful in routinely processed tissues. Arch Pathol Lab Med 1989: 113: 645.
4. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 1982: 95: 580.
5. Nelson WG, Battifora H, Santana H, Sun TT. Specific keratins as molecular markers for neoplasias with a stratified epithelial origin. Cancer Res 1984: 4: 1600.
6. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982: 31: 11.
7. Cooper D, Schermer A, Sun TT. Biology of disease. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations. Lab Invest 1985: 52: 243.
8. Battifora H, Kopinsky M. The influence of protease digestion and duration of fixation on the immunostaining of keratins. A comparison of formalin and ethanol fixation. J Histochem Cytochem 1986: 34: 1095.
9. DeLellis RA, Kwan P. Technical consideration in the immunohistochemical demonstration of intermediate filaments. Am J Surg Pathol 1988: 12: 17.
10. Makin CA, Bobrow LG, Bodmer WF. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol 1984: 37: 975.
11. Nelson W, Sun TT. The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J Cell Biol 1983: 97: 244.
12. Skerrow D, Skerrow CJ. Tonofilament differentiation in human epidermis: isolation and polypeptide chain composition of keratinocyte subpopulations. Exp Cell Res 1983: 143: 27.
13. Purkis PE, Steel JB, MacKenzie IC, Nathrath WJB, Leigh IM, Lane EB. Antibody markers of basal cells in complex epithelia. J Cell Sci 1990: 97: 39.
14. Markey AC, Lane EB, MacDonald DM, Leigh IM. Keratin expression in basal cell carcinomas. Br J Dermatol 1992: 126: 154.
15. Perkins W, Campbell I, Leigh IM, MacKie RM. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies. J Cutan Pathol 1992: 19: 476.
16. Gabbiani G, Kapanci Y, Barazzone P, Franke WW. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. Am J Pathol 1981: 104: 206.
17. Yazdi HM, Dardik I. Diagnostic immunocytochemistry and electron microscopy. New York: Igaku-Shoin, 1992: 63.
18. Hammar SP, Hallman KO. Unusual primary lung neoplasms: Simple cell and undifferentiated lung carcinomas expressing only vimentin. Ultrastruct Pathol 1990: 14: 407.
19. Goddard MJ, Wilson B, Grant JW. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. J Clin Pathol 1991: 44: 660.
20. Stoler A, Kopan R, Duvic M, Fuchs E. Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J Cell Biol 1988: 107: 27.
21. Prieto VG, McNutt NS. Immunohistochemical detection of keratin with the monoclonal antibody MNF116 is useful in the diagnosis of epidermolysis bullosa simplex. J Cutan Pathol 1994: 21: 118.
22. Tsubura A, Okada H, Sasaki M, Dairkee SH, Morii S. Immunohistochemical demonstration of keratins 8 and 14 in benign tumours of the skin appendage. Virchows Archiv A Pathol Anat Histopathol 1991: 418: 503.
23. Stoler A, Duvic M, Fuchs E. Unusual patterns of keratin expression in the overlying epidermis of patients with dermatofibromas: Biochemical alterations in the epidermis as a consequence of dermal tumors. J Invest Dermatol 1989: 93: 728.
24. Smoller BA, McNutt NS, Carter DM, Gottlieb AB, Hsu A, Krueger J. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Arch Dermatol 1990: 126: 78.
25. Sibley RK, Dahl D. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. Am J Surg Pathol 1985: 9: 109.
26. Battifora H, Silva EG. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma and oat cell carcinoma. Cancer 1986: 58: 1040.
27. Sibley RK, Dehner LP, Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. Am J Surg Pathol 1985: 9: 95.
28. Brown DC, Theaker JM, Banks PM, Gatter KC, Mason DY. Cytokeratin expression in smooth muscle and smooth muscle tumours. Histopathology 1987: 11: 477.
29. Norton AJ, Thomas JA, Isaacson PG. Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins. Histopathology 1987: 11: 487.